Moderna, Inc.
(NASDAQ : MRNA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -3.61%72.061.0%$1876.35m
AMGNAmgen, Inc. -3.01%196.631.3%$876.16m
REGNRegeneron Pharmaceuticals, Inc. 1.67%496.432.6%$847.70m
BIIBBiogen, Inc. -7.89%291.431.5%$699.33m
VRTXVertex Pharmaceuticals, Inc. -5.54%224.781.9%$555.74m
MRNAModerna, Inc. -0.40%29.830.0%$533.50m
ILMNIllumina, Inc. -7.47%252.723.5%$436.97m
ALXNAlexion Pharmaceuticals, Inc. -0.77%89.102.0%$283.85m
AAgilent Technologies, Inc. -4.19%68.621.6%$219.02m
EXASEXACT Sciences Corp. -3.12%56.1921.0%$188.32m
INCYIncyte Corp. 0.38%73.512.5%$177.26m
BMRNBioMarin Pharmaceutical, Inc. -1.55%83.194.3%$163.79m
SGENSeattle Genetics, Inc. -3.81%110.996.1%$163.05m
NVAXNovavax, Inc. 2.50%13.92114.7%$127.95m
ALNYAlnylam Pharmaceuticals, Inc. -3.79%104.728.7%$98.54m

Company Profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.